Skip to main content

Table 2 Fold changes in gene expression in cells treated with triptolide (55.5 nM)+LPS (1 μg/ml) as compared to those treated with LPS (1 μg/ml) alone.

From: MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages

a) Downregulation of LPS- stimulated genes by triptolide.

Gene

Accession No.

Gene name

Fold change in response to treatment

Symbol

  

LPS*

LPS+triptolide

Ccl2

NM_011333

Chemokine (C-C motif) ligand 2

19.90

-11.98

Ccl22

NM_011331

Chemokine (C-C motif) ligand 12

692.18

-8.53

Ccl3

NM_011337

Chemokine (C-C motif) ligand 3

4.48

-3.82

Ccl5

NM_013653

Chemokine (C-C motif) ligand 5

22.86

-19.05

Ccl7

NM_013654

Chemokine (C-C motif) ligand 7

96.67

-19.73

Ccl9

NM_011338

Chemokine (C-C motif) ligand 9

77.98

-30.74

Cxcl10

NM_021274

Chemokine (C-X-C motif) ligand 10

113.38

-39.18

Cxcl11

NM_019494

Chemokine (C-X-C motif) ligand 11

41.50

-13.01

Il10

NM_010548

Interleukin 10

55.52

-47.24

Il10ra

NM_008348

Interleukin 10 receptor, alpha

4.01

-3.21

Il13ra1

NM_133990

Interleukin 13 receptor, alpha 1

13.13

-11.17

Il18

NM_008360

Interleukin 18

17.33

-7.68

Il1a

NM_010554

Interleukin 1 alpha

2360.70

-102.68

Il1b

NM_008361

Interleukin 1 beta

1140.14

-55.02

Il1f6

NM_019450

Interleukin 1 family, member 6

51.09

-39.18

Il2rg

NM_013563

Interleukin 2 receptor, gamma chain

15.73

-5.66

Itgam

NM_008401

Integrin alpha M

7.09

-5.91

Itgb2

NM_008404

Integrin beta 2

3.82

-4.63

Spp1

NM_009263

Secreted phosphoprotein 1

5.60

-3.25

Tgfb1

NM_011577

Transforming growth factor, beta 1

4.27

-1161.68

Tnf

NM_013693

Tumor necrosis factor

58.69

-45.32

Tnfrsf1b

NM_011610

Tumor necrosis factor receptor superfamily, member 1b

90.82

-16.94

Bcl3

NM_033601

B-cell leukemia/lymphoma 3

20.51

-20.30

Crebbp

NM_001025432

CREB binding protein

2.92

-4.33

Csf2

NM_009969

Colony stimulating factor 2 (granulocyte-macrophage)

116.81

-61.53

Csf3

NM_009971

Colony stimulating factor 3 (granulocyte)

13568.7

-355.41

Gja1

NM_010288

Gap junction membrane channel protein alpha 1

4.65

-6.20

Il6

NM_031168

Interleukin 6

674.65

-256.59

Nfkb1

NM_008689

Nuclear factor of kappa light chain gene enhancer in B-cells 1, p105

32.63

-3.37

Nfkbia

NM_010907

Nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha

18.87

-2.93

Rel

NM_009044

Reticuloendotheliosis oncogene

114.40

-14.86

Ripk1

NM_009068

Receptor (TNFRSF)-interacting serine-threonine kinase 1

3.18

-7.80

Tlr1

NM_030682

Toll-like receptor 1

43.35

-18.55

Tlr4

NM_021297

Toll-like receptor 4

3.27

-5.40

Tnfaip3

NM_009397

Tumor necrosis factor, alpha-induced protein 3

56.41

-5.15

Cd14

NM_009841

CD14 antigen

4.01

-7.56

Cd86

NM_019388

CD86 antigen

4.24

-2.90

Ifnb1

NM_010510

Interferon beta 1, fibroblast

5.56

-7.15

Irf3

NM_016849

Interferon regulatory factor 3

3.02

-58.79

Ly86

NM_010745

Lymphocyte antigen 86

5.15

-8.21

Mapk8

NM_016700

Mitogen activated protein kinase 8

5.68

-11.06

Ptgs2

NM_011198

Prostaglandin-endoperoxide synthase 2

566.13

-51.89

b) Upregulation of LPS down regulated genes by triptolide.

Gene symbol

Accession No.

Gene Name

Fold change in response to treatment

   

LPS*

LPS+triptolide

Smad3

NM_016769

MAD homolog 3 (Drosophila)

-13.20

4.02

Mapk8ip3

NM_013931

Mitogen-activated protein kinase 8 interacting protein 3

-5.19

4.21

  1. * Fold changes for LPS treatments were determined by comparing to base level expressions in untreated cells
  2. Positive values (≥+3) indicate stimulation while negative values (≤-3) represent suppression of gene expression.